Specialists' perceptions of hereditary colorectal cancer screening in Newfoundland and Labrador

被引:1
|
作者
MacEachern, I.
Mathews, M. [1 ]
Green, J. [2 ]
Pullman, D.
机构
[1] Mem Univ Newfoundland, Div Community Hlth & Humanities, Hlth Sci Ctr, St John, NF A1B 3V6, Canada
[2] Mem Univ Newfoundland, Discipline Med Genet, St John, NF A1B 3V6, Canada
关键词
Colorectal cancer; familial; hereditary; specialists; screening;
D O I
10.3747/co.19.932
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Colorectal cancer (CRC) screening is particularly valuable in Newfoundland and Labrador (NL), where a substantial proportion of CRC cases have a hereditary link. We examined the perceptions of gastroenterologists and general surgeons with respect to screening practices for patients with hereditary CRC. Methods We surveyed all gastroenterologists and general surgeons in NL to determine demographic and professional practice characteristics and screening knowledge, practices, and attitudes for four groups of patients with hereditary CRC. Results Of the 43 eligible physicians, 36 (83.7%) responded. Most of the physicians surveyed knew the correct age to start screening, preferred screening by colonoscopy, had a systematic means in their own practice of prioritizing patients for screening, and felt that family doctors or patients (or both) should be responsible for monitoring screening compliance. Most physicians reported that patients with hereditary nonpolyposis CRC and familial adenomatous polyposis waited 3 months for screening; patients with a family history of CRC or adenomatous polyp waited 6 months or longer. Although respondents agreed on the need for a province-wide CRC registry [4.36 on a 5-point Likert scale (1 = strongly disagree; 5 = strongly agree)], they disagreed that wait times were reasonable (2.81) and that other health professionals should perform colonoscopies (2.86). They were equivocal about the need for centralized bookings (3.25) and about whether genetic testing is useful for prioritizing patients (3.25). Conclusions Gastroenterologists and general surgeons in NL. were knowledgeable about screening, but had varying opinions about individual roles in screening, wait times, and the means for prioritizing and providing screening for patients with hereditary CRC.
引用
收藏
页码:E123 / E128
页数:6
相关论文
共 50 条
  • [1] The Effects of Cancer Beliefs and Sociodemographic Factors on Colorectal Cancer Screening Behaviours in Newfoundland and Labrador
    Kong, Yujia
    Shaver, Lance Garrett
    Shi, Fuyan
    Mu, Huaxia
    Bu, Weixiao
    Etchegary, Holly
    Aubrey-Bassler, Kris
    Asghari, Shabnam
    Yi, Yanqing
    Wang, Peizhong Peter
    [J]. HEALTHCARE, 2022, 10 (12)
  • [2] Fourteen specialists resign in Newfoundland and Labrador in wage protest
    Moulton, Donalee
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2010, 182 (18) : E833 - E833
  • [3] SCREENING FOR HEREDITARY COLORECTAL-CANCER
    VASEN, HFA
    MECKLIN, JP
    KHAN, PM
    LYNCH, HT
    [J]. LANCET, 1994, 344 (8926): : 877 - 877
  • [5] Hereditary Colorectal Cancer: Genetics and Screening
    Brosens, Lodewijk A. A.
    Offerhaus, G. Johan A.
    Giardiello, Francis M.
    [J]. SURGICAL CLINICS OF NORTH AMERICA, 2015, 95 (05) : 1067 - +
  • [6] Screening interval in hereditary colorectal cancer
    不详
    [J]. EUROPEAN JOURNAL OF CANCER, 2003, 39 (04) : 408 - 408
  • [7] Hereditary colorectal cancer: Screening and management
    Ferrández A.
    DiSario J.A.
    [J]. Current Treatment Options in Oncology, 2002, 3 (6) : 459 - 474
  • [8] Screening and surveillance for hereditary colorectal cancer
    Kim, Hee Man
    Kim, Tae Il
    [J]. INTESTINAL RESEARCH, 2024, 22 (02) : 119 - 130
  • [9] The distribution of colorectal cancer in hereditary colorectal cancer syndromes and implications for screening
    Barrow, P. J.
    Newton, K.
    Lalloo, F.
    Hill, J.
    Evans, D. G.
    [J]. BRITISH JOURNAL OF SURGERY, 2013, 100 : 60 - 61
  • [10] Gynecologic screening in hereditary nonpolyposis colorectal cancer
    Rijcken, FEM
    Mourits, MJE
    Kleibeuker, JH
    Hollema, H
    van der Zee, AGJ
    [J]. GYNECOLOGIC ONCOLOGY, 2003, 91 (01) : 74 - 80